Olukotun Adeoye Y
SEC-identified person · CIK 1242615 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Tonix Pharmaceuticals Holding Corp. TNXP | Director | filed 2018 - 2026 |
| Arrowhead Research Corp ARWR | Director | filed 2020 - 2025 |
| Genesis Unicorn Capital Corp. GENQ | Chief Executive Officer | filed 2022 - 2022 |
| Diadexus, Inc. vxgn | Director | filed 2013 - 2014 |
| Bioclinica INC BITI | Director | filed 2008 - 2013 |
| Icagen INC ICGN | Director | filed 2006 - 2011 |
| VIA Pharmaceuticals, Inc. VIAP | Chief Medical Officer | filed 2007 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.